EV/EBITDA
-3.94
-0.09-2.34%
Thu, 28 Nov 2024 00:48:37 GMT
Summary:
Monte Rosa Therapeutics EV/EBITDA is currently -3.94, with a fall of -0.09 (-2.34%) during the most recent trading day. Over the past year, it has dropped by -2.91 (-282.52%). GLUE EV/EBITDA is now -363.53% below its all-time high of -0.85.GLUE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLUE EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -2.3% |
| 1 m1 month | -125.1% |
| 3 m3 months | -37.8% |
| 6 m6 months | -169.9% |
| ytdytd | -143.2% |
| 1 y1 year | -282.5% |
| 5 y5 years | - |
GLUE EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -1.75 | -125.1% | -4.54 | +13.2% |
| 3 m | 3 months | -1.75 | -125.1% | -4.54 | +13.2% |
| 6 m | 6 months | -1.18 | -233.9% | -4.54 | +13.2% |
| 1 y | 1 year | -0.96 | -310.4% | -4.54 | +13.2% |
| 3 y | 3 years | -0.85 | -363.5% | -10.13 | +61.1% |
| 5 y | 5 years | -0.85 | -363.5% | -34.19 | +88.5% |
| alltime | all time | -0.85 | -363.5% | -34.19 | +88.5% |
Monte Rosa Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -3.94(+143.2%) |
| 2023 | -1.62(-52.1%) |
| Date | Value |
|---|---|
| 2022 | -3.38(-60.4%) |
| 2021 | -8.54 |
FAQ
- What is Monte Rosa Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Monte Rosa Therapeutics?
- What is GLUE EV/EBITDA year-to-date change?
- What is Monte Rosa Therapeutics EV/EBITDA year-on-year change?
What is Monte Rosa Therapeutics EV/EBITDA?
The current EV/EBITDA of GLUE is -3.94
What is the all time high EV/EBITDA for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high EV/EBITDA is -0.85
What is GLUE EV/EBITDA year-to-date change?
Monte Rosa Therapeutics EV/EBITDA has changed by -2.32 (-143.21%) since the beginning of the year
What is Monte Rosa Therapeutics EV/EBITDA year-on-year change?
Over the past year, GLUE EV/EBITDA has changed by -2.91 (-282.52%)